GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (OTCPK:ARUXF) » Definitions » EBIT per Share

Acrux (ARUXF) EBIT per Share : $-0.02 (TTM As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Acrux EBIT per Share?

Acrux's EBIT per Share for the six months ended in Dec. 2024 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.02.

During the past 3 years, the average EBIT per Share Growth Rate was 26.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 26.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Acrux's EBIT per Share or its related term are showing as below:

ARUXF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -42.8   Med: -0.5   Max: 72.1
Current: 26

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Acrux was 72.10% per year. The lowest was -42.80% per year. And the median was -0.50% per year.

ARUXF's 3-Year EBIT Growth Rate is ranked better than
73.56% of 1218 companies
in the Biotechnology industry
Industry Median: 5.9 vs ARUXF: 26.00

Acrux's EBIT for the six months ended in Dec. 2024 was $-3.28 Mil.

Acrux EBIT per Share Historical Data

The historical data trend for Acrux's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrux EBIT per Share Chart

Acrux Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.06 -0.03 -0.01 -0.02

Acrux Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - -0.01 -0.01 -0.01

Acrux EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Acrux's EBIT per Share for the fiscal year that ended in Jun. 2024 is calculated as

EBIT per Share(A: Jun. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-5.694/289.500
=-0.02

Acrux's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

EBIT per Share(Q: Dec. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-3.275/300.439
=-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acrux  (OTCPK:ARUXF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Acrux EBIT per Share Related Terms

Thank you for viewing the detailed overview of Acrux's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Acrux Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (OTCPK:ARUXF) » Definitions » EBIT per Share
Comparable Companies
ASX:RCE ASX:CHM ASX:1AI ASX:BGT ASX:CMB ASX:ZLD ASX:NSB ASX:1AD ASX:IXC ASX:PAB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
FJY:Germany ACR:Australia
Address
103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003
Website
https://www.acrux.com.au
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.